"Postmenopausal status and early menopause as independent risk factors for cardiovascular disease: a meta-analysis". Menopause. 13 (2): 265-79. 2006. doi:10.1097/01.gme.0000218683.97338.ea. PMID16645540.
"Oestrogens for preventing recurrent urinary tract infection in postmenopausal women". Cochrane Database Syst Rev (2): CD005131. April 2008. doi:10.1002/14651858.CD005131.pub2. PMID18425910.
"Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and the North American Menopause Society". Menopause. 21 (10): 1063-8. October 2014. doi:10.1097/GME.0000000000000329. PMID25160739.
"The effects of hypoestrogenism on the vaginal wall: interference with the normal sexual response". The Journal of Sexual Medicine. 6 (1): 30-9. January 2009. doi:10.1111/j.1743-6109.2008.01052.x. PMID19170834.
"Genitourinary syndrome of menopause: an overview of clinical manifestations, pathophysiology, etiology, evaluation, and management". Am. J. Obstet. Gynecol. 215 (6): 704-711. December 2016. doi:10.1016/j.ajog.2016.07.045. PMID27472999.
"Functional Hypothalamic Amenorrhea: An Endocrine Society Clinical Practice Guideline". J. Clin. Endocrinol. Metab. 102 (5): 1413-1439. May 2017. doi:10.1210/jc.2017-00131. PMID28368518.
"American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the diagnosis and treatment of menopause". Endocrine Practice. 17 Suppl 6 (Supplement 6): 1-25. 2011. doi:10.4158/EP.17.S6.1. PMID22193047.
"Estrogens in men: clinical implications for sexual function and the treatment of testosterone deficiency". J Sex Med. 9 (6): 1681-96. June 2012. doi:10.1111/j.1743-6109.2012.02726.x. PMID22512993.
"Estradiol for the mitigation of adverse effects of androgen deprivation therapy". Endocr. Relat. Cancer. 24 (8): R297-R313. August 2017. doi:10.1530/ERC-17-0153. PMID28667081.
"The effect of estrogen on the sexual interest of castrated males: Implications to prostate cancer patients on androgen-deprivation therapy". Crit. Rev. Oncol. Hematol. 87 (3): 224-38. September 2013. doi:10.1016/j.critrevonc.2013.01.006. PMID23484454.
nih.gov
ncbi.nlm.nih.gov
"Postmenopausal status and early menopause as independent risk factors for cardiovascular disease: a meta-analysis". Menopause. 13 (2): 265-79. 2006. doi:10.1097/01.gme.0000218683.97338.ea. PMID16645540.
"Oestrogens for preventing recurrent urinary tract infection in postmenopausal women". Cochrane Database Syst Rev (2): CD005131. April 2008. doi:10.1002/14651858.CD005131.pub2. PMID18425910.
"Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and the North American Menopause Society". Menopause. 21 (10): 1063-8. October 2014. doi:10.1097/GME.0000000000000329. PMID25160739.
"The effects of hypoestrogenism on the vaginal wall: interference with the normal sexual response". The Journal of Sexual Medicine. 6 (1): 30-9. January 2009. doi:10.1111/j.1743-6109.2008.01052.x. PMID19170834.
Office of the Surgeon General (US) (2004). Diseases of Bone. Office of the Surgeon General (US). 22 Eylül 2021 tarihinde kaynağından arşivlendi. Erişim tarihi: 16 Eylül 2022.
"Genitourinary syndrome of menopause: an overview of clinical manifestations, pathophysiology, etiology, evaluation, and management". Am. J. Obstet. Gynecol. 215 (6): 704-711. December 2016. doi:10.1016/j.ajog.2016.07.045. PMID27472999.
"Functional Hypothalamic Amenorrhea: An Endocrine Society Clinical Practice Guideline". J. Clin. Endocrinol. Metab. 102 (5): 1413-1439. May 2017. doi:10.1210/jc.2017-00131. PMID28368518.
"American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the diagnosis and treatment of menopause". Endocrine Practice. 17 Suppl 6 (Supplement 6): 1-25. 2011. doi:10.4158/EP.17.S6.1. PMID22193047.
"Estrogens in men: clinical implications for sexual function and the treatment of testosterone deficiency". J Sex Med. 9 (6): 1681-96. June 2012. doi:10.1111/j.1743-6109.2012.02726.x. PMID22512993.
"Estradiol for the mitigation of adverse effects of androgen deprivation therapy". Endocr. Relat. Cancer. 24 (8): R297-R313. August 2017. doi:10.1530/ERC-17-0153. PMID28667081.
"The effect of estrogen on the sexual interest of castrated males: Implications to prostate cancer patients on androgen-deprivation therapy". Crit. Rev. Oncol. Hematol. 87 (3): 224-38. September 2013. doi:10.1016/j.critrevonc.2013.01.006. PMID23484454.
Feingold, Kenneth R.; Anawalt, Bradley; Boyce, Alison; Chrousos, George, (Ed.) (2000), "Menopause and Hormone Replacement", Endotext, South Dartmouth (MA): MDText.com, Inc., PMID25905278, 26 Eylül 2020 tarihinde kaynağından arşivlendi, erişim tarihi: 16 Eylül 2022
Office of the Surgeon General (US) (2004). Diseases of Bone. Office of the Surgeon General (US). 22 Eylül 2021 tarihinde kaynağından arşivlendi. Erişim tarihi: 16 Eylül 2022.